Genome editing to 're-write' wrongs

Article metrics

The NIH has launched the Somatic Cell Genome Editing (SCGE) programme to accelerate the development of safer and more effective genome-editing therapeutics.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Tebas, P. et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 370, 901–910 (2014).

  2. 2

    Kaiser, J. A human has been injected with gene-editing tools to cure his disabling disease. Here's what you need to know. Science http://www.sciencemag.org/news/2017/2011/human-has-been-injected-gene-editing-tools-cure-his-disabling-disease-here-s-what-you (2017).

  3. 3

    Komor, A. C., Badran, A. H. & Liu, D. R. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 168, 20–36 (2017).

  4. 4

    Cyranoski, D. CRISPR gene-editing tested in a person for the first time. Nature 539, 479 (2016).

  5. 5

    Freedman, L. P., Cockburn, I. M. & Simcoe, T. S. The economics of reproducibility in preclinical research. PLOS Biol. 13, e1002165 (2015).

Download references

Author information

Correspondence to Philip J. Brooks.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

RELATED LINKS

ClinicalTrials.gov

DARPA Safe Genes programme

FDA OTAT

NIH Common Fund Somatic Cell Genome Editing programme

NIH: Rigor and Reproducibility

NIST Gene Editing Consortium

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading